New patent for Celgene drug POMALYST
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent for Celgene drug POMALYST appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.